论文部分内容阅读
放射性核素显象的阳性显象剂,对肿瘤而言,多为非特异性。因此,寻找对肿瘤有较高特异性的显象剂是核医学显象的主要研究方向之一。1895年,Hericourt 和Richet 制备了一种抗人成骨肉瘤抗血清治疗胸壁纤维肉瘤和
Positive radionuclide imaging agents are mostly non-specific for tumors. Therefore, finding imaging agents with higher specificity for tumors is one of the main research directions in nuclear medicine imaging. In 1895, Hericourt and Richet prepared an anti-human osteosarcoma antiserum for the treatment of chest wall fibrosarcoma and